Literature DB >> 15319082

Herpes simplex virus type 2 transmission: risk factors and virus shedding.

Anna Wald1.   

Abstract

The prevalence of herpes simplex virus type 2 (HSV-2) infection is not uniform, with some populations bearing a greater burden of disease than others. Potential risk factors that influence HSV-2 transmission rates have been identified, largely from observational prospective and retrospective studies. Risk factors can be categorized as biological or behavioural. These risk factors can be markers of population subgroups that are likely to have acquired, or are at high risk of acquiring, HSV-2. Major factors associated with HSV-2 seropositivity include female gender, race (black), history of sexually transmitted infections, increasing numbers of sexual partners, sexual contact with commercial sex workers and low socio-economic status or level of education. Age-related risk factors are important, likely reflecting the cumulative number of sex partners, age of initiation of sexual activity, and duration of sexual activity as well as chronic nature of HSV-2 infection. Understanding and identifying these factors may help to direct interventions to reduce HSV-2 transmission and acquisition. An important contributing factor to the spread of genital herpes is unrecognized virus shedding, often allowing transmission from individuals who are not aware that they are infected or who are not having a recurrence. Antiviral therapy reduces both the frequency and amount of HSV reactivation, whereas behavioural risk factors can be addressed in part with educational initiatives. Clinical history is a poor predictor of HSV-2 infection and type-specific serological testing is recommended to detect HSV-2 seropositivity.

Entities:  

Mesh:

Year:  2004        PMID: 15319082

Source DB:  PubMed          Journal:  Herpes        ISSN: 0969-7667


  33 in total

1.  Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.

Authors:  Warren Phipps; Misty Saracino; Amalia Magaret; Stacy Selke; Mike Remington; Meei-Li Huang; Terri Warren; Corey Casper; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2010-12-09       Impact factor: 5.226

2.  High Rates of Herpes Simplex Virus Type 2 Infection in Homeless Women: Informing Public Health Strategies.

Authors:  J Daniel Kelly; Jennifer Cohen; Barbara Grimes; Susan S Philip; Sheri D Weiser; Elise D Riley
Journal:  J Womens Health (Larchmt)       Date:  2016-05-31       Impact factor: 2.681

3.  High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients.

Authors:  Laurent Andréoletti; Emmanuel Piednoir; Jérôme Legoff; Véronique Brodard; Isabelle Beguinot; Christophe Strady; Christine Rouger; Christophe Piketty; Ali Si-Mohamed; Michel Daniel Kazatchkine; Jean-Elie Malkin; Laurent Bélec
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United States.

Authors:  Pragna Patel; Tim Bush; Kenneth H Mayer; Sheila Desai; Keith Henry; Edgar Turner Overton; Lois Conley; John Hammer; John T Brooks
Journal:  Sex Transm Dis       Date:  2012-02       Impact factor: 2.830

5.  Prevalence and factors associated with HSV-2 and hepatitis B infections among truck drivers crossing the southern Brazilian border.

Authors:  Adriana A Pinho; Magda Chinaglia; Sheri A Lippman; Arthur Reingold; Ricardo Sobhie Diaz; Maria Cecilia Sucupira; Kimberly Page; Juan Díaz
Journal:  Sex Transm Infect       Date:  2011-10-03       Impact factor: 3.519

6.  Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases.

Authors:  Sabra L Klein
Journal:  Bioessays       Date:  2012-09-26       Impact factor: 4.345

7.  Sexual behaviors and sexually transmitted infections in a nationally representative sample of women veterans and nonveterans.

Authors:  Keren Lehavot; Jodie G Katon; Emily C Williams; Karin M Nelson; Carolyn M Gardella; Gayle E Reiber; Tracy L Simpson
Journal:  J Womens Health (Larchmt)       Date:  2013-12-13       Impact factor: 2.681

8.  A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes.

Authors:  Ronald L Veselenak; Mark Shlapobersky; Richard B Pyles; Qun Wei; Sean M Sullivan; Nigel Bourne
Journal:  Vaccine       Date:  2012-10-04       Impact factor: 3.641

9.  Social and behavioral correlates of sexually transmitted infection- and HIV-discordant sexual partnerships in Bushwick, Brooklyn, New York.

Authors:  Maria R Khan; Melissa Bolyard; Milagros Sandoval; Pedro Mateu-Gelabert; Beatrice Krauss; Sevgi O Aral; Samuel R Friedman
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-01       Impact factor: 3.731

10.  Herpes simplex virus type 2 infection among young uncircumcised men in Kisumu, Kenya.

Authors:  S D Mehta; S Moses; K Agot; W Agingu; C Parker; J O Ndinya-Achola; R C Bailey
Journal:  Sex Transm Infect       Date:  2007-09-12       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.